Efficacy and safety of low doses of beta-blocker agents combined with amiodarone in refractory ventricular tachycardia

Twenty patients aged 55 +/- 16 years with 40 chronic ventricular tachycardias (VT) refractory to 4.6 +/- 1.9 antiarrhythmic drugs, used alone or in combination, were managed by low doses of beta-blocker agents combined with oral amiodarone (Am), either after loading (1.2 g for 7 days, n: 5) or reloa...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Pacing and clinical electrophysiology Ročník 11; číslo 11 Pt 2; s. 1984
Hlavní autori: Tonet, J, Frank, R, Fontaine, G, Grosgogeat, Y
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States 01.11.1988
Predmet:
ISSN:0147-8389
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Twenty patients aged 55 +/- 16 years with 40 chronic ventricular tachycardias (VT) refractory to 4.6 +/- 1.9 antiarrhythmic drugs, used alone or in combination, were managed by low doses of beta-blocker agents combined with oral amiodarone (Am), either after loading (1.2 g for 7 days, n: 5) or reloading (1.2 g for 4 days, n: 15) of Am. All patients proved refractory to Am alone. Seven VT were also refractory to endocardial catheter fulguration in six patients. Thirteen patients had coronary artery disease, three had arrhythmogenic right ventricular dysplasia, two had dilated cardiomyopathy, one had valvular disease, and one had no structural heart disease. Ten patients had an EF less than 30%. Ten patients were in NYHA functional class three. VT was permanent in three patients, daily in three, weekly in seven, paroxysmal in seven. In 11 patients, VT occurred both at day and night. In 11 patients, decrease of the sinus cycle preceeded VT. Oral administration of a daily low dose of a beta blocker agent (acebutolol 100 mg, betaxolol 5-10 mg, metoprolol 50 mg, nadolol 20-40 mg, pindolol 2.5 mg, propanolol 30 mg, sotalol 80-160 mg, terta-tolol 2.5 mg) combined with 400 mg/day of Am suppressed VT episodes in all patients. None presented heart failure or collapse. The mean reduction of the heart rate was 15% (65 to 55/min). At discharge, exercise ECG (n: 14) induced non sustained VT in two patients. At programmed electrical stimulation (PES) (n: 15), VT was no longer inducible in 4 patients, was slower, well-tolerated in nine patients, and remained inducible at the same rate in only two patients.
AbstractList Twenty patients aged 55 +/- 16 years with 40 chronic ventricular tachycardias (VT) refractory to 4.6 +/- 1.9 antiarrhythmic drugs, used alone or in combination, were managed by low doses of beta-blocker agents combined with oral amiodarone (Am), either after loading (1.2 g for 7 days, n: 5) or reloading (1.2 g for 4 days, n: 15) of Am. All patients proved refractory to Am alone. Seven VT were also refractory to endocardial catheter fulguration in six patients. Thirteen patients had coronary artery disease, three had arrhythmogenic right ventricular dysplasia, two had dilated cardiomyopathy, one had valvular disease, and one had no structural heart disease. Ten patients had an EF less than 30%. Ten patients were in NYHA functional class three. VT was permanent in three patients, daily in three, weekly in seven, paroxysmal in seven. In 11 patients, VT occurred both at day and night. In 11 patients, decrease of the sinus cycle preceeded VT. Oral administration of a daily low dose of a beta blocker agent (acebutolol 100 mg, betaxolol 5-10 mg, metoprolol 50 mg, nadolol 20-40 mg, pindolol 2.5 mg, propanolol 30 mg, sotalol 80-160 mg, terta-tolol 2.5 mg) combined with 400 mg/day of Am suppressed VT episodes in all patients. None presented heart failure or collapse. The mean reduction of the heart rate was 15% (65 to 55/min). At discharge, exercise ECG (n: 14) induced non sustained VT in two patients. At programmed electrical stimulation (PES) (n: 15), VT was no longer inducible in 4 patients, was slower, well-tolerated in nine patients, and remained inducible at the same rate in only two patients.Twenty patients aged 55 +/- 16 years with 40 chronic ventricular tachycardias (VT) refractory to 4.6 +/- 1.9 antiarrhythmic drugs, used alone or in combination, were managed by low doses of beta-blocker agents combined with oral amiodarone (Am), either after loading (1.2 g for 7 days, n: 5) or reloading (1.2 g for 4 days, n: 15) of Am. All patients proved refractory to Am alone. Seven VT were also refractory to endocardial catheter fulguration in six patients. Thirteen patients had coronary artery disease, three had arrhythmogenic right ventricular dysplasia, two had dilated cardiomyopathy, one had valvular disease, and one had no structural heart disease. Ten patients had an EF less than 30%. Ten patients were in NYHA functional class three. VT was permanent in three patients, daily in three, weekly in seven, paroxysmal in seven. In 11 patients, VT occurred both at day and night. In 11 patients, decrease of the sinus cycle preceeded VT. Oral administration of a daily low dose of a beta blocker agent (acebutolol 100 mg, betaxolol 5-10 mg, metoprolol 50 mg, nadolol 20-40 mg, pindolol 2.5 mg, propanolol 30 mg, sotalol 80-160 mg, terta-tolol 2.5 mg) combined with 400 mg/day of Am suppressed VT episodes in all patients. None presented heart failure or collapse. The mean reduction of the heart rate was 15% (65 to 55/min). At discharge, exercise ECG (n: 14) induced non sustained VT in two patients. At programmed electrical stimulation (PES) (n: 15), VT was no longer inducible in 4 patients, was slower, well-tolerated in nine patients, and remained inducible at the same rate in only two patients.
Twenty patients aged 55 +/- 16 years with 40 chronic ventricular tachycardias (VT) refractory to 4.6 +/- 1.9 antiarrhythmic drugs, used alone or in combination, were managed by low doses of beta-blocker agents combined with oral amiodarone (Am), either after loading (1.2 g for 7 days, n: 5) or reloading (1.2 g for 4 days, n: 15) of Am. All patients proved refractory to Am alone. Seven VT were also refractory to endocardial catheter fulguration in six patients. Thirteen patients had coronary artery disease, three had arrhythmogenic right ventricular dysplasia, two had dilated cardiomyopathy, one had valvular disease, and one had no structural heart disease. Ten patients had an EF less than 30%. Ten patients were in NYHA functional class three. VT was permanent in three patients, daily in three, weekly in seven, paroxysmal in seven. In 11 patients, VT occurred both at day and night. In 11 patients, decrease of the sinus cycle preceeded VT. Oral administration of a daily low dose of a beta blocker agent (acebutolol 100 mg, betaxolol 5-10 mg, metoprolol 50 mg, nadolol 20-40 mg, pindolol 2.5 mg, propanolol 30 mg, sotalol 80-160 mg, terta-tolol 2.5 mg) combined with 400 mg/day of Am suppressed VT episodes in all patients. None presented heart failure or collapse. The mean reduction of the heart rate was 15% (65 to 55/min). At discharge, exercise ECG (n: 14) induced non sustained VT in two patients. At programmed electrical stimulation (PES) (n: 15), VT was no longer inducible in 4 patients, was slower, well-tolerated in nine patients, and remained inducible at the same rate in only two patients.
Author Grosgogeat, Y
Frank, R
Fontaine, G
Tonet, J
Author_xml – sequence: 1
  givenname: J
  surname: Tonet
  fullname: Tonet, J
  organization: Service de Rythmologie, Hôpital Jean Rostand, Ivry
– sequence: 2
  givenname: R
  surname: Frank
  fullname: Frank, R
– sequence: 3
  givenname: G
  surname: Fontaine
  fullname: Fontaine, G
– sequence: 4
  givenname: Y
  surname: Grosgogeat
  fullname: Grosgogeat, Y
BackLink https://www.ncbi.nlm.nih.gov/pubmed/2463576$$D View this record in MEDLINE/PubMed
BookMark eNotkD1PwzAYhD0UQSn8BCSLgS3Bjh3HGVHFl4TEAnP12n5NXZK42Gkh_54iesvppEen052T2RAHJOSas5IfdLspeS1ZoXndlrzVuhwNU0Lo8mdG5ozLptBCt2fkPOcNY0wxWZ-S00oqUTdqTvb33gcLdqIwOJrB4zjR6GkXv6mLGfNfMDhCYbpoPzFR-MBhzNTG3oQBHf0O45pCH6KDdJhGw0AT-gR2jGmi-wOcgt11kOgIdj1ZSC7ABTnx0GW8PPqCvD_cvy2fipfXx-fl3UthRSVloaxDrYVB2VjjwUBttHSct954XzVQMfSNAG7qVoAwoHwrZMWRKScEVnW1IDf_vdsUv3aYx1UfssWugwHjLq8arVijan0Ar47gzvToVtsUekjT6nhU9Qs1am_P
CitedBy_id crossref_primary_10_1016_0002_9149_90_91322_W
crossref_primary_10_1016_S0140_6736_89_90488_1
crossref_primary_10_1111_j_1540_8159_1996_tb03409_x
crossref_primary_10_1016_S0002_9149_99_00706_7
crossref_primary_10_1007_s11936_005_0032_0
crossref_primary_10_1046_j_1540_8167_2000_01309_x
crossref_primary_10_1016_S0300_9572_00_00207_0
crossref_primary_10_1016_S1388_9842_99_00071_9
crossref_primary_10_1016_0002_8703_92_90405_K
crossref_primary_10_1016_j_acmx_2013_11_002
crossref_primary_10_1016_S0002_9149_97_00836_9
crossref_primary_10_1161_01_CIR_99_17_2268
crossref_primary_10_1016_0002_8703_93_90063_F
crossref_primary_10_1111_j_1540_8159_2012_03371_x
crossref_primary_10_1016_0002_9149_94_90933_4
crossref_primary_10_1016_j_jacep_2025_02_023
crossref_primary_10_1016_S0735_1097_99_00234_X
crossref_primary_10_1136_hrt_70_1_8
crossref_primary_10_1016_S0002_9149_99_00696_7
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1111/j.1540-8159.1988.tb06338.x
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
ExternalDocumentID 2463576
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.3N
.GA
.Y3
04C
05W
0R~
10A
123
1OB
1OC
29O
2QV
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5VS
66C
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOJX
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHEFC
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMSDO
BMXJE
BPMNR
BROTX
BRXPI
BY8
C45
CAG
CGR
COF
CS3
CUY
CVF
D-6
D-7
D-E
D-F
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DXH
EAD
EAP
EAS
EBC
EBD
EBS
ECF
ECM
ECT
ECV
EIF
EIHBH
EJD
EMB
EMK
EMOBN
ENC
EPT
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
I-F
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NPM
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
Q~Q
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
V8K
VVN
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQ9
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
ZZTAW
~IA
~WT
7X8
AEYWJ
AGQPQ
AIQQE
ID FETCH-LOGICAL-c3244-6cde883be47cbfaba5b84d119fbff27a20ef73a1b593a3ba6f93421e06d33e252
IEDL.DBID 7X8
ISSN 0147-8389
IngestDate Sun Nov 09 09:02:10 EST 2025
Wed Feb 19 02:35:20 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 11 Pt 2
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3244-6cde883be47cbfaba5b84d119fbff27a20ef73a1b593a3ba6f93421e06d33e252
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 2463576
PQID 78607658
PQPubID 23479
ParticipantIDs proquest_miscellaneous_78607658
pubmed_primary_2463576
PublicationCentury 1900
PublicationDate November 1988
PublicationDateYYYYMMDD 1988-11-01
PublicationDate_xml – month: 11
  year: 1988
  text: November 1988
PublicationDecade 1980
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Pacing and clinical electrophysiology
PublicationTitleAlternate Pacing Clin Electrophysiol
PublicationYear 1988
SSID ssj0006045
Score 1.4162475
Snippet Twenty patients aged 55 +/- 16 years with 40 chronic ventricular tachycardias (VT) refractory to 4.6 +/- 1.9 antiarrhythmic drugs, used alone or in...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 1984
SubjectTerms Adrenergic beta-Antagonists - administration & dosage
Adrenergic beta-Antagonists - therapeutic use
Adult
Aged
Amiodarone - therapeutic use
Cardiac Pacing, Artificial
Drug Therapy, Combination
Female
Follow-Up Studies
Humans
Male
Middle Aged
Tachycardia - diagnosis
Tachycardia - drug therapy
Time Factors
Title Efficacy and safety of low doses of beta-blocker agents combined with amiodarone in refractory ventricular tachycardia
URI https://www.ncbi.nlm.nih.gov/pubmed/2463576
https://www.proquest.com/docview/78607658
Volume 11
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dS9xAEF_OnhRftLWKp9bug69pk-xmdw8KIqL0QQ8fKtzbMbs7S4-2iSbnlfz3nU1y9En64EsgkMAwOzufv5lh7Nyj0i5FnSDZ3kQqkIkFn9KBAHnzThbWdltLbvVsZubz6f2Ifd30wkRY5UYndoraVy7myL9ooyjkLszF41MSd0bF2uqwQGOLjQU5MhHQpef_ZoWrVA4ARtLDZJeHkaMDjicCAgzZ8s8UdZuYH1UUrHUDkF5wNDuDc7P3OlLfsd3B0eSXvWS8ZyMs99nbu6GU_oGtr-PwCHAth9LzBgKuWl4F_qv6w33VYBNfLK4gsWTvfmLNIXZhNZxooGgaPY8pXA6_l5WHuiqRL0tO5rbuFvi0POIou-Qi1HwF7kfrOlk8YA8319-vviXDEobEka8lE-U8GiMsSu1sAAuFNdJn2TTYEHINeYpBC8hsMRUgLKgwFTLPMFVeCMyL_JC9KYmII8axQERB3zhtZJF6EgqnU0sepc8K4tmEfdrwc0FCHisXUGL13Cw2HJ2ww_5IFo_9LI5FLuNAPXX8319P2E486b6N8JSNA91u_Mi23Xq1bOqzTnToObu_-wuDbNBl
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Efficacy+and+safety+of+low+doses+of+beta-blocker+agents+combined+with+amiodarone+in+refractory+ventricular+tachycardia&rft.jtitle=Pacing+and+clinical+electrophysiology&rft.au=Tonet%2C+J&rft.au=Frank%2C+R&rft.au=Fontaine%2C+G&rft.au=Grosgogeat%2C+Y&rft.date=1988-11-01&rft.issn=0147-8389&rft.volume=11&rft.issue=11+Pt+2&rft.spage=1984&rft_id=info:doi/10.1111%2Fj.1540-8159.1988.tb06338.x&rft_id=info%3Apmid%2F2463576&rft_id=info%3Apmid%2F2463576&rft.externalDocID=2463576
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0147-8389&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0147-8389&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0147-8389&client=summon